Amgen (AMGN) PT Lowered to $310 at Piper Sandler; 'Well-Positioned To Transcend Key LOE's'
Tweet Send to a Friend
Piper Sandler analyst David Amsellem lowered the price target on Amgen (NASDAQ: AMGN) to $310.00 (from $344.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
